These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33428177)

  • 21. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
    Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
    Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
    Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
    CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): Study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Guo ZN; Zhang KJ; Zhang P; Qu Y; Abuduxukuer R; Nguyen TN; Chen HS; Yang Y
    Eur Stroke J; 2024 Jun; 9(2):510-514. PubMed ID: 38196129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.
    Chalos V; A van de Graaf R; Roozenbeek B; C G M van Es A; M den Hertog H; Staals J; van Dijk L; F M Jenniskens S; J van Oostenbrugge R; H van Zwam W; B W E M Roos Y; B L M Majoie C; F Lingsma H; van der Lugt A; W J Dippel D;
    Trials; 2020 Jul; 21(1):644. PubMed ID: 32665035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial.
    Zhang Q; Wang A; Xu Q; Xia X; Tian X; Zhang Y; Li X; Yang X; Wang X; Peng J; Li Y; Liu L; Jin S; Meng X; Zhao X;
    JAMA Netw Open; 2023 Aug; 6(8):e2328828. PubMed ID: 37578791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
    Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
    Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
    Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial.
    Culp WC; Onteddu SS; Brown A; Nalleballe K; Sharma R; Skinner RD; Witt T; Roberson PK; Marsh JD
    J Vasc Interv Radiol; 2019 Aug; 30(8):1244-1250.e1. PubMed ID: 31349978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.
    Zhu Y; Zhang G; Zhao J; Li D; Yan X; Liu J; Liu X; Zhao H; Xia J; Zhang X; Li Z; Zhang B; Guo Z; Feng L; Zhang Z; Qu F; Zhao G
    Clin Drug Investig; 2013 Oct; 33(10):755-60. PubMed ID: 23949899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolysis with Recombinant Human Prourokinase 4.5-6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial.
    Song H; Wang Y; Ma Q; Chen H; Liu B; Yang Y; Zhu J; Zhao S; Jin X; Li Y; Wang Y; Zhu R; Zhao L; Liu J; Feng W; Liu R; Ji X; Wang Y
    CNS Drugs; 2024 Jan; 38(1):67-75. PubMed ID: 38030867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin supplementation may benefit patients with acute ischemic stroke not eligible for reperfusion therapies: Results of a pilot study.
    Mehrpooya M; Mazdeh M; Rahmani E; Khazaie M; Ahmadimoghaddam D
    J Clin Neurosci; 2022 Dec; 106():66-75. PubMed ID: 36270095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial.
    Fu Y; Tang R; Chen R; Wang A; Ren J; Zhu S; Feng X; Fan D
    Stroke Vasc Neurol; 2024 Feb; 9(1):90-95. PubMed ID: 37308251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.